KWCKeith W. CrawfordRPh, PhDSlideset26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025NIH Initiatives and Research Promoting Antiviral Pharmacology - Keith W. CrawfordView Slideset
Video26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #7 An Enzymatic Assay for Rapid and Minimally Instrumented Ganciclovir Triphosphate Monitoring in Infants With Congenital Cytomegalovirus - Willow ChernoskeView Video
Slideset26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #7 An Enzymatic Assay for Rapid and Minimally Instrumented Ganciclovir Triphosphate Monitoring in Infants With Congenital Cytomegalovirus - Willow ChernoskeView Slideset
Video26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #6 Target Attainment of Valganciclovir Prophylaxis against Cytomegalovirus - Suzanne WenkerView Video
Slideset26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #6 Target Attainment of Valganciclovir Prophylaxis against Cytomegalovirus - Suzanne WenkerView Slideset
VideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #5 Plasma Bictegravir/Emtricitabine/Tenofovir Alafenamide Concentrations in Transgender Women with HIV on Estrogen-Based Gender-Affirming Hormone Therapy in Comparison to Cisgender Women Living with HIV - Shawnalyn SunagawaView Video
SlidesetHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #5 Plasma Bictegravir/Emtricitabine/Tenofovir Alafenamide Concentrations in Transgender Women with HIV on Estrogen-Based Gender-Affirming Hormone Therapy in Comparison to Cisgender Women Living with HIV - Shawnalyn SunagawaView Slideset
VideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #4 Pharmacokinetic Parameters of Bictegravir in Breastmilk of Healthy, Lactating Volunteers without HIV After a Single Dose of 50mg (Co-Formulated with Emtricitabine 200mg and Tenofovir Alafenamide 25mg) - Lena Christina Wendy van der Wekken-PasView Video
SlidesetHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #4 Pharmacokinetic Parameters of Bictegravir in Breastmilk of Healthy, Lactating Volunteers without HIV After a Single Dose of 50mg (Co-Formulated with Emtricitabine 200mg and Tenofovir Alafenamide 25mg) - Lena Christina Wendy van der Wekken-PasView Slideset
VideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #3 Therapeutic Drug Monitoring of Dolutegravir in Children and Adolescents Living with HIV: A Retrospective Study - Émilie PiloteView Video
SlidesetHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #3 Therapeutic Drug Monitoring of Dolutegravir in Children and Adolescents Living with HIV: A Retrospective Study - Émilie PiloteView Slideset
AOAdeniyi OlagunjuBPharm, MRes, PhDVideo26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025New Models for Drug Exposure and Safety During Pregnancy - Adeniyi OlagunjuView Video
